Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXSM vs $CORT | Chartloom

Compare

$AXSM vs $CORT

Axsome Therapeutics Inc · Corcept Therapeutics Inc

AXSM

Axsome Therapeutics Inc

CORT

Corcept Therapeutics Inc

Compare $AXSM vs $CORT

Comparing Axsome Therapeutics Inc and Corcept Therapeutics Inc

AXSMAxsome Therapeutics Inc

CORTCorcept Therapeutics Inc

AXSMAxsome Therapeutics Inc

Market cap

$8.04B

P/E (TTM)

—

Forward P/E (NTM)

211.90x

Forward P/S (NTM)

6.58x

Rev growth (TTM)

56.9%

YTD performance

-12.5%

52W performance

28.4%

FCF yield

-0.9%

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXSM

CORT

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

CORT

Corcept Therapeutics Inc

Market Cap

AXSM$8.04B

CORT$12.73B

Enterprise Value

AXSM$7.93B

CORT$12.62B

Price

AXSM$156.32

CORT$117.80

P/E Ratio

AXSMN/A

CORT252.72x

P/S Ratio

AXSM10.36x

CORT15.33x

EV/Sales

AXSM10.21x

CORT15.19x

EV/EBITDA

AXSM0.00x

CORT1,442.80x

P/B Ratio

AXSM105.86x

CORT18.56x

P/FCF Ratio

AXSMN/A

CORT119.10x

EV/FCF

AXSM-110.16x

CORT118.06x

PEG Ratio

AXSMN/A

CORTN/A

Forward P/E (NTM)

AXSM211.90x

CORT28.94x

Forward P/S (NTM)

AXSM6.58x

CORT8.27x

Revenue (TTM)

AXSM$777M

CORT$831M

Revenue Growth (YoY)

AXSM56.9%

CORT16.0%

Forward Rev Growth

AXSM59.9%

CORT48.8%

Gross Margin (TTM)

AXSM93.2%

CORT98.3%

Operating Margin (TTM)

AXSM0.0%

CORT0.8%

EBITDA Margin (TTM)

AXSM-23.0%

CORT1.0%

Net Margin (TTM)

AXSM-24.7%

CORT6.6%

FCF Margin (TTM)

AXSM-9.3%

CORT12.9%

Net Income (TTM)

AXSM$-192M

CORT$55M

FCF (TTM)

AXSM$-72M

CORT$107M

EPS (TTM)

AXSM-$3.70

CORT$0.47

ROE (TTM)

AXSM-25560.0%

CORT8.4%

ROA (TTM)

AXSM-2705.0%

CORT6.6%

ROIC (TTM)

AXSM-7042.0%

CORT8.4%

Cash

AXSM$320M

CORT$111M

Debt

AXSM$202M

CORT$0

Net Cash/Debt

AXSM$117M

CORT$111M

Current Ratio (TTM)

AXSM1.43x

CORT2.86x

Quick Ratio (TTM)

AXSM1.30x

CORT2.63x

Debt/Equity (TTM)

AXSM2.43x

CORT0.00x

Debt/Assets (TTM)

AXSM0.0%

CORT0.0%

Interest Coverage (TTM)

AXSMN/A

CORTN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

CORT0.00x

Beta

AXSM0.79

CORT0.52

52W Performance

AXSM28.4%

CORT59.3%

YTD Performance

AXSM-12.5%

CORT208.4%

% from 52W High

AXSM-39.9%

CORT-6.8%

% from 52W Low

AXSM31.1%

CORT311.0%

Asset Turnover (TTM)

AXSM1.10x

CORT0.99x

FCF Yield (TTM)

AXSM-0.9%

CORT0.8%

Earnings Yield (TTM)

AXSM-2.4%

CORT0.4%

Dividend Yield (TTM)

AXSMN/A

CORTN/A

Rule of 40

AXSM47.6

CORT28.9

EV/GP/RG

AXSM0.19

CORT0.18

Ticker research

View AXSM research View CORT research

Metric	AXSM Axsome Therapeutics Inc	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$8.04B	$12.73B
Enterprise Value	$7.93B	$12.62B
Price	$156.32	$117.80
P/E Ratio	N/A	252.72x
P/S Ratio	10.36x	15.33x
EV/Sales	10.21x	15.19x
EV/EBITDA	0.00x	1,442.80x
P/B Ratio	105.86x	18.56x
P/FCF Ratio	N/A	119.10x
EV/FCF	-110.16x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	28.94x
Forward P/S (NTM)	6.58x	8.27x
Revenue & Growth
Revenue (TTM)	$777M	$831M
Revenue Growth (YoY)	56.9%	16.0%
Forward Rev Growth	59.9%	48.8%
Profitability
Gross Margin (TTM)	93.2%	98.3%
Operating Margin (TTM)	0.0%	0.8%
EBITDA Margin (TTM)	-23.0%	1.0%
Net Margin (TTM)	-24.7%	6.6%
FCF Margin (TTM)	-9.3%	12.9%
Net Income (TTM)	$-192M	$55M
FCF (TTM)	$-72M	$107M
EPS (TTM)	-$3.70	$0.47
ROE (TTM)	-25560.0%	8.4%
ROA (TTM)	-2705.0%	6.6%
ROIC (TTM)	-7042.0%	8.4%
Financial Health
Cash	$320M	$111M
Debt	$202M	$0
Net Cash/Debt	$117M	$111M
Current Ratio (TTM)	1.43x	2.86x
Quick Ratio (TTM)	1.30x	2.63x
Debt/Equity (TTM)	2.43x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	0.52
52W Performance	28.4%	59.3%
YTD Performance	-12.5%	208.4%
% from 52W High	-39.9%	-6.8%
% from 52W Low	31.1%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.99x
FCF Yield (TTM)	-0.9%	0.8%
Earnings Yield (TTM)	-2.4%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	28.9
EV/GP/RG	0.19	0.18
Ticker research	View AXSM research	View CORT research

Valuation

P/E Ratio

CORT

252.72x

P/S Ratio

AXSM

10.36x

CORT

15.33x

EV/FCF

AXSM

-110.16x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

AXSM

56.9%

CORT

16.0%

Forward Revenue Growth

AXSM

59.9%

CORT

48.8%

Profitability & performance

Gross Margin

CORT

98.3%

AXSM

93.2%

ROE

CORT

8.4%

AXSM

-25560.0%

FCF Yield %

CORT

0.8%

AXSM

-0.9%

52-Week Performance

CORT

59.3%

AXSM

28.4%

Detailed metrics comparison

AXSM

Axsome Therapeutics Inc

CORT

Corcept Therapeutics Inc

Market Cap

AXSM$8.04B

CORT$12.73B

Enterprise Value

AXSM$7.93B

CORT$12.62B

Price

AXSM$156.32

CORT$117.80

P/E Ratio

AXSMN/A

CORT252.72x

P/S Ratio

AXSM10.36x

CORT15.33x

EV/Sales

AXSM10.21x

CORT15.19x

EV/EBITDA

AXSM0.00x

CORT1,442.80x

P/B Ratio

AXSM105.86x

CORT18.56x

P/FCF Ratio

AXSMN/A

CORT119.10x

EV/FCF

AXSM-110.16x

CORT118.06x

PEG Ratio

AXSMN/A

CORTN/A

Forward P/E (NTM)

AXSM211.90x

CORT28.94x

Forward P/S (NTM)

AXSM6.58x

CORT8.27x

Revenue (TTM)

AXSM$777M

CORT$831M

Revenue Growth (YoY)

AXSM56.9%

CORT16.0%

Forward Rev Growth

AXSM59.9%

CORT48.8%

Gross Margin (TTM)

AXSM93.2%

CORT98.3%

Operating Margin (TTM)

AXSM0.0%

CORT0.8%

EBITDA Margin (TTM)

AXSM-23.0%

CORT1.0%

Net Margin (TTM)

AXSM-24.7%

CORT6.6%

FCF Margin (TTM)

AXSM-9.3%

CORT12.9%

Net Income (TTM)

AXSM$-192M

CORT$55M

FCF (TTM)

AXSM$-72M

CORT$107M

EPS (TTM)

AXSM-$3.70

CORT$0.47

ROE (TTM)

AXSM-25560.0%

CORT8.4%

ROA (TTM)

AXSM-2705.0%

CORT6.6%

ROIC (TTM)

AXSM-7042.0%

CORT8.4%

Cash

AXSM$320M

CORT$111M

Debt

AXSM$202M

CORT$0

Net Cash/Debt

AXSM$117M

CORT$111M

Current Ratio (TTM)

AXSM1.43x

CORT2.86x

Quick Ratio (TTM)

AXSM1.30x

CORT2.63x

Debt/Equity (TTM)

AXSM2.43x

CORT0.00x

Debt/Assets (TTM)

AXSM0.0%

CORT0.0%

Interest Coverage (TTM)

AXSMN/A

CORTN/A

Net Debt/EBITDA (TTM)

AXSM0.00x

CORT0.00x

Beta

AXSM0.79

CORT0.52

52W Performance

AXSM28.4%

CORT59.3%

YTD Performance

AXSM-12.5%

CORT208.4%

% from 52W High

AXSM-39.9%

CORT-6.8%

% from 52W Low

AXSM31.1%

CORT311.0%

Asset Turnover (TTM)

AXSM1.10x

CORT0.99x

FCF Yield (TTM)

AXSM-0.9%

CORT0.8%

Earnings Yield (TTM)

AXSM-2.4%

CORT0.4%

Dividend Yield (TTM)

AXSMN/A

CORTN/A

Rule of 40

AXSM47.6

CORT28.9

EV/GP/RG

AXSM0.19

CORT0.18

Ticker research

View AXSM research View CORT research

Metric	AXSM Axsome Therapeutics Inc	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$8.04B	$12.73B
Enterprise Value	$7.93B	$12.62B
Price	$156.32	$117.80
P/E Ratio	N/A	252.72x
P/S Ratio	10.36x	15.33x
EV/Sales	10.21x	15.19x
EV/EBITDA	0.00x	1,442.80x
P/B Ratio	105.86x	18.56x
P/FCF Ratio	N/A	119.10x
EV/FCF	-110.16x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	211.90x	28.94x
Forward P/S (NTM)	6.58x	8.27x
Revenue & Growth
Revenue (TTM)	$777M	$831M
Revenue Growth (YoY)	56.9%	16.0%
Forward Rev Growth	59.9%	48.8%
Profitability
Gross Margin (TTM)	93.2%	98.3%
Operating Margin (TTM)	0.0%	0.8%
EBITDA Margin (TTM)	-23.0%	1.0%
Net Margin (TTM)	-24.7%	6.6%
FCF Margin (TTM)	-9.3%	12.9%
Net Income (TTM)	$-192M	$55M
FCF (TTM)	$-72M	$107M
EPS (TTM)	-$3.70	$0.47
ROE (TTM)	-25560.0%	8.4%
ROA (TTM)	-2705.0%	6.6%
ROIC (TTM)	-7042.0%	8.4%
Financial Health
Cash	$320M	$111M
Debt	$202M	$0
Net Cash/Debt	$117M	$111M
Current Ratio (TTM)	1.43x	2.86x
Quick Ratio (TTM)	1.30x	2.63x
Debt/Equity (TTM)	2.43x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	0.52
52W Performance	28.4%	59.3%
YTD Performance	-12.5%	208.4%
% from 52W High	-39.9%	-6.8%
% from 52W Low	31.1%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	1.10x	0.99x
FCF Yield (TTM)	-0.9%	0.8%
Earnings Yield (TTM)	-2.4%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	47.6	28.9
EV/GP/RG	0.19	0.18
Ticker research	View AXSM research	View CORT research